The estimated Net Worth of Donna Nichols is at least 15.3 千$ dollars as of 1 December 2016. Donna Nichols owns over 2,500 units of Recro Pharma Inc stock worth over 15,341$ and over the last 11 years Donna sold REPH stock worth over 0$.
Donna has made over 3 trades of the Recro Pharma Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Donna exercised 2,500 units of REPH stock worth 5,225$ on 1 December 2016.
The largest trade Donna's ever made was exercising 2,500 units of Recro Pharma Inc stock on 1 December 2016 worth over 5,225$. On average, Donna trades about 440 units every 85 days since 2014. As of 1 December 2016 Donna still owns at least 7,340 units of Recro Pharma Inc stock.
You can see the complete history of Donna Nichols stock trades at the bottom of the page.
Donna's mailing address filed with the SEC is 490 LAPP ROAD, , MALVERN, PA, 19355.
Over the last 11 years, insiders at Recro Pharma Inc have traded over 25,533,136$ worth of Recro Pharma Inc stock and bought 3,055,820 units worth 22,429,197$ . The most active insiders traders include Healthcare Master Fund Ltd ...、Investment Company, Inc. Awm、James E Deerfield Mgmt L.P..... On average, Recro Pharma Inc executives and independent directors trade stock every 31 days with the average trade being worth of 151,953$. The most recent stock trade was executed by J David Jr Enloe on 15 March 2022, trading 512 units of REPH stock currently worth 1,004$.
Recro Pharma Inc. is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing. With an expertise in solving complex manufacturing problems, Recro is a leading CDMO providing oral solid dosage form development, end-to-end regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market.
Recro Pharma Inc executives and other stock owners filed with the SEC include: